MLL2 protein is a prognostic marker for gastrointestinal diffuse large B-cell lymphoma.
Haige Ye(Wenzhou Medical University), Kaiyan Yang(Wenzhou Medical University), Shenmeng Gao(Wenzhou Medical University), Kang Yu(Wenzhou Medical University), Yongyong Ma(Wenzhou Medical University), Bin Liang(University of Chinese Academy of Sciences), Lu Lu(Fudan University), Bei Ge(Wenzhou Medical University)
PubMed
January 1, 2015
Cited by 14
Related Papers
The cumulative burden of surviving childhood cancer: an initial report from the St Jude Lifetime Cohort Study (SJLIFE)
|The Lancet|2017|856
SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells
|Emerging Microbes & Infections|2021|474
Emerging SARS-CoV-2 variants expand species tropism to murines
|EBioMedicine|2021|192
High neutralizing antibody titer in intensive care unit patients with COVID-19
|Emerging Microbes & Infections|2020|150